Two leading figures whose work has helped shape diabetes research, prevention and care have been recognised in a prestigious list of the UK’s most influential Black, Asian and minority ethnic people in health.
Professor Kamlesh Khunti CBE, an internationally renowned type 2 diabetes researcher at the University of Leicester, and Louise Ansari MBE, former Director of Prevention of Type 2 Diabetes at Diabetes UK, have both been named in the Health Service Journal’s (HSJ) 2026 list of the 75 most influential Black, Asian and minority ethnic people in health.
This independent webinar has received sponsorship from a medical technology company. The sponsor has had no editorial input into or control over the agenda, content development, speaker selection or opinions expressed during the webinar.
The Diabetes & Obesity Pharmacy Alliance is launching a series of free webinars to help pharmacists navigate the evolving landscape of diabetes and obesity care, with sessions exploring injectable therapies, medicines optimisation and the complexities of patient care.
As the prevalence of diabetes and obesity continues to rise and treatment options advance, pharmacists have an increasingly important role in prevention, early intervention, patient education and long-term disease management.
Healthcare professionals are being reminded that insulin pen needles previously branded BD are now available under new embecta product names and packaging, with the needles themselves remaining unchanged.
Following the transition, embecta has updated the branding across its insulin pen needle portfolio, introducing new product names and packaging while retaining the same needles that people living with diabetes are familiar with.
The message behind the transition is simple: same trusted needle, new name and packaging.
News from CVRM Professional Care 2026
Healthcare professionals from across the UK came together at the inaugural CVRM Professional Care to explore how greater collaboration between specialities could transform care for people living with multiple long-term conditions.
Held at Olympia London on October 20 and 21, the event brought together experts from cardiovascular, renal, diabetes and metabolic care to share knowledge and explore how more integrated healthcare services could improve patient outcomes.
Testing for and managing early type 1 diabetes was the subject of a speaker session on the opening morning of CVRM Professional Care.
Parth Narendran, Professor of Diabetes Medicine at the University of Birmingham and adult diabetologist at The Queen Elizabeth Hospital in Birmingham, spoke about early detection of the condition and how his team manages patients identified with early stage type 1 diabetes.
Delegates at the conference, which is the first of its kind to shine a spotlight on some of the biggest developments shaping cardiovascular, renal and metabolic care, heard about the treatment that is now available for people with early stage type 1 diabetes, including NICE-approved immunotherapy medication.
Treating the person rather than individual conditions is crucial to implementing integrated cardiovascular, renal and metabolic care, delegates at CVRM Professional Care heard. Dr Kevin Fernando, a Portfolio GP with an Extended Role in Diabetes at NHS Lothian, chaired the two-day conference. Click here.
Patients developing complex cardiovascular, renal and metabolic (CVRM) conditions that require hospital treatment represent a “failure of our systems upstream”, a consultant pharmacist and NHS England clinical director told delegates at CVRM Professional Care 2026. Click here.
Community pharmacies could play a much bigger role in preventing cardiovascular disease by offering cholesterol testing, risk assessments and potentially prescribing treatment, a leading NHS England clinical director told delegates at CVRM Professional Care 2026. Click here.
Women with polycystic ovary syndrome (PCOS) are being diagnosed too late and need better monitoring for metabolic and cardiovascular complications, a leading women’s health specialist warned at CVRM Professional Care 2026. Click here.
Patients with multiple long-term conditions must be put “in the driver’s seat” when making decisions about their treatment, a cardiovascular, renal and metabolic (CVRM) specialist told delegates at CVRM Professional Care 2026 today (October 21). Click here.
Hospital admissions should be seen as a vital opportunity to address gaps in diabetes, cardiovascular, renal and metabolic care, a leading diabetologist has told delegates at CVRM Professional Care 2026. Click here.
New research published in The Lancet Regional Health Americas shows that around half of people diagnosed with early-onset type 2 diabetes before the age of 45 can achieve remission through a low-energy diet combined with a structured exercise programme. Click here.
A new wearable microsensor designed to make glucose monitoring less invasive could be available in Europe within the next two years, following a partnership between Ascensia Diabetes Care and Sava Technologies. The two companies have announced an agreement to support the development and introduction of the technology, which is being designed to continuously measure glucose levels just beneath the skin. Click here.
This event is sponsored by industry, including pharmaceutical companies.
Diabetes UK independently develops the programme; sponsors have no influence over the content of speakers, aside from clearly-identified sponsor sessions.
Registration is now open for the Diabetes UK Professional Conference 2027, which will bring together more than 2,400 healthcare professionals, researchers and industry partners to explore the latest developments in diabetes prevention, treatment and care.
Taking place from April 20 to 22, 2027, at Liverpool Experience Campus, the three-day event will focus on translating the latest research, evidence and innovation into improvements in diabetes care.
Thousands of people living with diabetes could be missing out on early detection of chronic kidney disease because of low uptake of a simple urine test, kidney health experts have warned.
Despite being a recommended part of routine diabetes care, the urine albumin-to-creatinine ratio (uACR) test remains the least frequently completed of the nine key diabetes care processes, raising concerns that opportunities to prevent serious kidney and cardiovascular complications are being missed.
In the first of a new opinion series, Dr Partha Kar questions whether NHS diabetes care has reached a tipping point – and whether prioritising just three key areas could be the bold decision needed to reverse declining standards.
Let’s be honest. We are in troubling times. Whether in diabetes care or more broadly, there is no question that there is an underlying anxiety, even among the most optimistic in diabetes care. Things seem to be on a slide compared with where they have been. This may very well be a reflection of the present financial conundrum the NHS finds itself in, and diabetes is no exception to the continued decline the healthcare system faces...read more.
Bringing you the latest jobs from around the country within the field of diabetes.
Diabetes Midwife - Liverpool Women's NHS Foundation Trust
Diabetes Nurse - Hersham Surgery
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
